Trials / Conditions / CNV
CNV
6 registered clinical trials studyying CNV — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD NCT05407636 | AbbVie | Phase 3 |
| Recruiting | Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One NCT04704921 | AbbVie | Phase 2 / Phase 3 |
| Completed | Reinterpretation of CNV With Unknown Significance: a 5-year Retrospective Analysis NCT04575350 | Central Hospital, Nancy, France | — |
| Withdrawn | Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneratio NCT00726466 | Vitreous -Retina- Macula Consultants of New York | Phase 1 |
| Completed | Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT) NCT00564291 | Sebastian Wolf | — |
| Completed | Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration NCT01570790 | Johns Hopkins University | Phase 1 / Phase 2 |